Global Embolization Particle Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
According to APO Research, The global Embolization Particle market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report presents an overview of global market for Embolization Particle, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Embolization Particle, also provides the sales of main regions and countries. Of the upcoming market potential for Embolization Particle, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Embolization Particle sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Embolization Particle market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Embolization Particle sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V. and Alicon, etc.
Embolization Particle segment by Company
1. To analyze and research the global Embolization Particle status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Embolization Particle market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Embolization Particle significant trends, drivers, influence factors in global and regions.
6. To analyze Embolization Particle competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolization Particle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Embolization Particle and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolization Particle.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Embolization Particle market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Embolization Particle industry.
Chapter 3: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Embolization Particle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Embolization Particle in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
According to APO Research, The global Embolization Particle market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report presents an overview of global market for Embolization Particle, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Embolization Particle, also provides the sales of main regions and countries. Of the upcoming market potential for Embolization Particle, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Embolization Particle sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Embolization Particle market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Embolization Particle sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V. and Alicon, etc.
Embolization Particle segment by Company
- Sirtex Medical
- Merit Medical
- Cook Medical
- BTG Medical
- Boston Scientific Corporation
- Terumo Corporation
- HENGRUI Medical
- INterface BIOmaterials B.V.
- Alicon
- Microspheres
- Particles (e.g. PVA Particles, Gelfoam Particles)
- Drug-eluting Beads (DEBs)
- Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
- Uterine Fibroid Embolization
- Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
- Liver Tumor Embolization
- Trauma Embolization
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Embolization Particle status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Embolization Particle market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Embolization Particle significant trends, drivers, influence factors in global and regions.
6. To analyze Embolization Particle competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolization Particle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Embolization Particle and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolization Particle.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Embolization Particle market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Embolization Particle industry.
Chapter 3: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Embolization Particle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Embolization Particle in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Embolization Particle Sales Value (2019-2030)
1.2.2 Global Embolization Particle Sales Volume (2019-2030)
1.2.3 Global Embolization Particle Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 EMBOLIZATION PARTICLE MARKET DYNAMICS
2.1 Embolization Particle Industry Trends
2.2 Embolization Particle Industry Drivers
2.3 Embolization Particle Industry Opportunities and Challenges
2.4 Embolization Particle Industry Restraints
3 EMBOLIZATION PARTICLE MARKET BY COMPANY
3.1 Global Embolization Particle Company Revenue Ranking in 2023
3.2 Global Embolization Particle Revenue by Company (2019-2024)
3.3 Global Embolization Particle Sales Volume by Company (2019-2024)
3.4 Global Embolization Particle Average Price by Company (2019-2024)
3.5 Global Embolization Particle Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Embolization Particle Company Manufacturing Base & Headquarters
3.7 Global Embolization Particle Company, Product Type & Application
3.8 Global Embolization Particle Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Embolization Particle Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Embolization Particle Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 EMBOLIZATION PARTICLE MARKET BY TYPE
4.1 Embolization Particle Type Introduction
4.1.1 Microspheres
4.1.2 Particles (e.g. PVA Particles, Gelfoam Particles)
4.1.3 Drug-eluting Beads (DEBs)
4.1.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
4.2 Global Embolization Particle Sales Volume by Type
4.2.1 Global Embolization Particle Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Embolization Particle Sales Volume by Type (2019-2030)
4.2.3 Global Embolization Particle Sales Volume Share by Type (2019-2030)
4.3 Global Embolization Particle Sales Value by Type
4.3.1 Global Embolization Particle Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Embolization Particle Sales Value by Type (2019-2030)
4.3.3 Global Embolization Particle Sales Value Share by Type (2019-2030)
5 EMBOLIZATION PARTICLE MARKET BY APPLICATION
5.1 Embolization Particle Application Introduction
5.1.1 Uterine Fibroid Embolization
5.1.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
5.1.3 Liver Tumor Embolization
5.1.4 Trauma Embolization
5.1.5 Others
5.2 Global Embolization Particle Sales Volume by Application
5.2.1 Global Embolization Particle Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Embolization Particle Sales Volume by Application (2019-2030)
5.2.3 Global Embolization Particle Sales Volume Share by Application (2019-2030)
5.3 Global Embolization Particle Sales Value by Application
5.3.1 Global Embolization Particle Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Embolization Particle Sales Value by Application (2019-2030)
5.3.3 Global Embolization Particle Sales Value Share by Application (2019-2030)
6 EMBOLIZATION PARTICLE MARKET BY REGION
6.1 Global Embolization Particle Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Embolization Particle Sales by Region (2019-2030)
6.2.1 Global Embolization Particle Sales by Region: 2019-2024
6.2.2 Global Embolization Particle Sales by Region (2025-2030)
6.3 Global Embolization Particle Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Embolization Particle Sales Value by Region (2019-2030)
6.4.1 Global Embolization Particle Sales Value by Region: 2019-2024
6.4.2 Global Embolization Particle Sales Value by Region (2025-2030)
6.5 Global Embolization Particle Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Embolization Particle Sales Value (2019-2030)
6.6.2 North America Embolization Particle Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Embolization Particle Sales Value (2019-2030)
6.7.2 Europe Embolization Particle Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Embolization Particle Sales Value (2019-2030)
6.8.2 Asia-Pacific Embolization Particle Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Embolization Particle Sales Value (2019-2030)
6.9.2 Latin America Embolization Particle Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Embolization Particle Sales Value (2019-2030)
6.10.2 Middle East & Africa Embolization Particle Sales Value Share by Country, 2023 VS 2030
7 EMBOLIZATION PARTICLE MARKET BY COUNTRY
7.1 Global Embolization Particle Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Embolization Particle Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Embolization Particle Sales by Country (2019-2030)
7.3.1 Global Embolization Particle Sales by Country (2019-2024)
7.3.2 Global Embolization Particle Sales by Country (2025-2030)
7.4 Global Embolization Particle Sales Value by Country (2019-2030)
7.4.1 Global Embolization Particle Sales Value by Country (2019-2024)
7.4.2 Global Embolization Particle Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.5.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.6.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.7.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.8.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.9.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.10.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.11.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.12.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.13.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.14.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.15.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.16.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.17.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.18.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.19.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.20.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.21.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.22.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.23.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Sirtex Medical
8.1.1 Sirtex Medical Comapny Information
8.1.2 Sirtex Medical Business Overview
8.1.3 Sirtex Medical Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.1.4 Sirtex Medical Embolization Particle Product Portfolio
8.1.5 Sirtex Medical Recent Developments
8.2 Merit Medical
8.2.1 Merit Medical Comapny Information
8.2.2 Merit Medical Business Overview
8.2.3 Merit Medical Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.2.4 Merit Medical Embolization Particle Product Portfolio
8.2.5 Merit Medical Recent Developments
8.3 Cook Medical
8.3.1 Cook Medical Comapny Information
8.3.2 Cook Medical Business Overview
8.3.3 Cook Medical Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.3.4 Cook Medical Embolization Particle Product Portfolio
8.3.5 Cook Medical Recent Developments
8.4 BTG Medical
8.4.1 BTG Medical Comapny Information
8.4.2 BTG Medical Business Overview
8.4.3 BTG Medical Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.4.4 BTG Medical Embolization Particle Product Portfolio
8.4.5 BTG Medical Recent Developments
8.5 Boston Scientific Corporation
8.5.1 Boston Scientific Corporation Comapny Information
8.5.2 Boston Scientific Corporation Business Overview
8.5.3 Boston Scientific Corporation Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
8.5.5 Boston Scientific Corporation Recent Developments
8.6 Terumo Corporation
8.6.1 Terumo Corporation Comapny Information
8.6.2 Terumo Corporation Business Overview
8.6.3 Terumo Corporation Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.6.4 Terumo Corporation Embolization Particle Product Portfolio
8.6.5 Terumo Corporation Recent Developments
8.7 HENGRUI Medical
8.7.1 HENGRUI Medical Comapny Information
8.7.2 HENGRUI Medical Business Overview
8.7.3 HENGRUI Medical Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.7.4 HENGRUI Medical Embolization Particle Product Portfolio
8.7.5 HENGRUI Medical Recent Developments
8.8 INterface BIOmaterials B.V.
8.8.1 INterface BIOmaterials B.V. Comapny Information
8.8.2 INterface BIOmaterials B.V. Business Overview
8.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
8.8.5 INterface BIOmaterials B.V. Recent Developments
8.9 Alicon
8.9.1 Alicon Comapny Information
8.9.2 Alicon Business Overview
8.9.3 Alicon Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.9.4 Alicon Embolization Particle Product Portfolio
8.9.5 Alicon Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Embolization Particle Value Chain Analysis
9.1.1 Embolization Particle Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Embolization Particle Sales Mode & Process
9.2 Embolization Particle Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Embolization Particle Distributors
9.2.3 Embolization Particle Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Embolization Particle Sales Value (2019-2030)
1.2.2 Global Embolization Particle Sales Volume (2019-2030)
1.2.3 Global Embolization Particle Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 EMBOLIZATION PARTICLE MARKET DYNAMICS
2.1 Embolization Particle Industry Trends
2.2 Embolization Particle Industry Drivers
2.3 Embolization Particle Industry Opportunities and Challenges
2.4 Embolization Particle Industry Restraints
3 EMBOLIZATION PARTICLE MARKET BY COMPANY
3.1 Global Embolization Particle Company Revenue Ranking in 2023
3.2 Global Embolization Particle Revenue by Company (2019-2024)
3.3 Global Embolization Particle Sales Volume by Company (2019-2024)
3.4 Global Embolization Particle Average Price by Company (2019-2024)
3.5 Global Embolization Particle Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Embolization Particle Company Manufacturing Base & Headquarters
3.7 Global Embolization Particle Company, Product Type & Application
3.8 Global Embolization Particle Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Embolization Particle Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Embolization Particle Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 EMBOLIZATION PARTICLE MARKET BY TYPE
4.1 Embolization Particle Type Introduction
4.1.1 Microspheres
4.1.2 Particles (e.g. PVA Particles, Gelfoam Particles)
4.1.3 Drug-eluting Beads (DEBs)
4.1.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
4.2 Global Embolization Particle Sales Volume by Type
4.2.1 Global Embolization Particle Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Embolization Particle Sales Volume by Type (2019-2030)
4.2.3 Global Embolization Particle Sales Volume Share by Type (2019-2030)
4.3 Global Embolization Particle Sales Value by Type
4.3.1 Global Embolization Particle Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Embolization Particle Sales Value by Type (2019-2030)
4.3.3 Global Embolization Particle Sales Value Share by Type (2019-2030)
5 EMBOLIZATION PARTICLE MARKET BY APPLICATION
5.1 Embolization Particle Application Introduction
5.1.1 Uterine Fibroid Embolization
5.1.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
5.1.3 Liver Tumor Embolization
5.1.4 Trauma Embolization
5.1.5 Others
5.2 Global Embolization Particle Sales Volume by Application
5.2.1 Global Embolization Particle Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Embolization Particle Sales Volume by Application (2019-2030)
5.2.3 Global Embolization Particle Sales Volume Share by Application (2019-2030)
5.3 Global Embolization Particle Sales Value by Application
5.3.1 Global Embolization Particle Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Embolization Particle Sales Value by Application (2019-2030)
5.3.3 Global Embolization Particle Sales Value Share by Application (2019-2030)
6 EMBOLIZATION PARTICLE MARKET BY REGION
6.1 Global Embolization Particle Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Embolization Particle Sales by Region (2019-2030)
6.2.1 Global Embolization Particle Sales by Region: 2019-2024
6.2.2 Global Embolization Particle Sales by Region (2025-2030)
6.3 Global Embolization Particle Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Embolization Particle Sales Value by Region (2019-2030)
6.4.1 Global Embolization Particle Sales Value by Region: 2019-2024
6.4.2 Global Embolization Particle Sales Value by Region (2025-2030)
6.5 Global Embolization Particle Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Embolization Particle Sales Value (2019-2030)
6.6.2 North America Embolization Particle Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Embolization Particle Sales Value (2019-2030)
6.7.2 Europe Embolization Particle Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Embolization Particle Sales Value (2019-2030)
6.8.2 Asia-Pacific Embolization Particle Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Embolization Particle Sales Value (2019-2030)
6.9.2 Latin America Embolization Particle Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Embolization Particle Sales Value (2019-2030)
6.10.2 Middle East & Africa Embolization Particle Sales Value Share by Country, 2023 VS 2030
7 EMBOLIZATION PARTICLE MARKET BY COUNTRY
7.1 Global Embolization Particle Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Embolization Particle Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Embolization Particle Sales by Country (2019-2030)
7.3.1 Global Embolization Particle Sales by Country (2019-2024)
7.3.2 Global Embolization Particle Sales by Country (2025-2030)
7.4 Global Embolization Particle Sales Value by Country (2019-2030)
7.4.1 Global Embolization Particle Sales Value by Country (2019-2024)
7.4.2 Global Embolization Particle Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.5.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.6.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.7.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.8.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.9.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.10.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.11.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.12.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.13.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.14.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.15.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.16.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.17.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.18.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.19.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.20.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.21.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.22.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Embolization Particle Sales Value Growth Rate (2019-2030)
7.23.2 Global Embolization Particle Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Embolization Particle Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Sirtex Medical
8.1.1 Sirtex Medical Comapny Information
8.1.2 Sirtex Medical Business Overview
8.1.3 Sirtex Medical Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.1.4 Sirtex Medical Embolization Particle Product Portfolio
8.1.5 Sirtex Medical Recent Developments
8.2 Merit Medical
8.2.1 Merit Medical Comapny Information
8.2.2 Merit Medical Business Overview
8.2.3 Merit Medical Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.2.4 Merit Medical Embolization Particle Product Portfolio
8.2.5 Merit Medical Recent Developments
8.3 Cook Medical
8.3.1 Cook Medical Comapny Information
8.3.2 Cook Medical Business Overview
8.3.3 Cook Medical Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.3.4 Cook Medical Embolization Particle Product Portfolio
8.3.5 Cook Medical Recent Developments
8.4 BTG Medical
8.4.1 BTG Medical Comapny Information
8.4.2 BTG Medical Business Overview
8.4.3 BTG Medical Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.4.4 BTG Medical Embolization Particle Product Portfolio
8.4.5 BTG Medical Recent Developments
8.5 Boston Scientific Corporation
8.5.1 Boston Scientific Corporation Comapny Information
8.5.2 Boston Scientific Corporation Business Overview
8.5.3 Boston Scientific Corporation Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
8.5.5 Boston Scientific Corporation Recent Developments
8.6 Terumo Corporation
8.6.1 Terumo Corporation Comapny Information
8.6.2 Terumo Corporation Business Overview
8.6.3 Terumo Corporation Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.6.4 Terumo Corporation Embolization Particle Product Portfolio
8.6.5 Terumo Corporation Recent Developments
8.7 HENGRUI Medical
8.7.1 HENGRUI Medical Comapny Information
8.7.2 HENGRUI Medical Business Overview
8.7.3 HENGRUI Medical Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.7.4 HENGRUI Medical Embolization Particle Product Portfolio
8.7.5 HENGRUI Medical Recent Developments
8.8 INterface BIOmaterials B.V.
8.8.1 INterface BIOmaterials B.V. Comapny Information
8.8.2 INterface BIOmaterials B.V. Business Overview
8.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
8.8.5 INterface BIOmaterials B.V. Recent Developments
8.9 Alicon
8.9.1 Alicon Comapny Information
8.9.2 Alicon Business Overview
8.9.3 Alicon Embolization Particle Sales, Value and Gross Margin (2019-2024)
8.9.4 Alicon Embolization Particle Product Portfolio
8.9.5 Alicon Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Embolization Particle Value Chain Analysis
9.1.1 Embolization Particle Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Embolization Particle Sales Mode & Process
9.2 Embolization Particle Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Embolization Particle Distributors
9.2.3 Embolization Particle Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
